Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma

It is unknown whether tyrosine kinase inhibitors targeting epidermal growth factor receptor (EGFR) can be discontinued in patients in whom EGFR-mutated lung cancer has well stabilised. We present a case of a 73-year-old Japanese woman with no history of smoking. Right pulmonary lower lobectomy, lymp...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Case Rep
Main Authors: Yamanaka, Yumie, Seki, Yoshitaka, Ishikawa, Takeo, Kuwano, Kazuyoshi
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2019
Fag:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357919/
https://ncbi.nlm.nih.gov/pubmed/30709831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-227383
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker